NFA
KERX

Nationwide Fund Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Nationwide Fund Advisors’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-50,732
Closed -$360K – 2886
2017
Q3 		$360K Buy
50,732
+4,714
+10% +$33.9K ﹤0.01% 2346
2017
Q2 		$333K Hold
46,018
– – ﹤0.01% 2390
2017
Q1 		$283K Sell
46,018
-3,622
-7% -$19.8K ﹤0.01% 2443
2016
Q4 		$291K Sell
49,640
-2,370
-5% -$12.9K ﹤0.01% 2446
2016
Q3 		$276K Hold
52,010
– – ﹤0.01% 2471
2016
Q2 		$344K Sell
52,010
-13,858
-21% -$77.5K ﹤0.01% 2346
2016
Q1 		$308K Sell
65,868
-2,857
-4% -$11.4K ﹤0.01% 2323
2015
Q4 		$347K Buy
68,725
+1,749
+3% +$8.31K ﹤0.01% 2291
2015
Q3 		$236K Hold
66,976
– – ﹤0.01% 2480
2015
Q2 		$668K Sell
66,976
-7,101
-10% -$76.1K ﹤0.01% 2083
2015
Q1 		$943K Buy
74,077
+4,638
+7% +$59.6K ﹤0.01% 1917
2014
Q4 		$983K Sell
69,439
-903
-1% -$14K ﹤0.01% 1824
2014
Q3 		$967K Buy
70,342
+54
+0.1% +$827 ﹤0.01% 1849
2014
Q2 		$1.08M Sell
70,288
-230,293
-77% -$3.26M ﹤0.01% 1813
2014
Q1 		$5.12M Buy
300,581
+85,642
+40% +$1.29M 0.02% 855
2013
Q4 		$2.78M Buy
214,939
+149,954
+231% +$1.79M 0.01% 1278
2013
Q3 		$656K Buy
64,985
+3,283
+5% +$29.2K ﹤0.01% 2079
2013
Q2 		$461K Buy
+61,702
New +$482K ﹤0.01% 2051

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nationwide Fund Advisors's KERX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2017, closing a stake of 50,732 shares — an estimated $360K sold.

Nationwide Fund Advisors first reported a position in KERX in Q2 2013 and held it in 18 quarters. The position peaked at $5.12M in Q1 2014. 129 funds tracked by Wall St. Rank hold KERX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 50,732 Keryx Biopharmaceuticals Inc shares in Q4 2017, an estimated $360K.
  • Nationwide Fund Advisors first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Keryx Biopharmaceuticals Inc position peaked at $5.12M in Q1 2014.
  • 129 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.